Beverly Winikoff
#156,785
Most Influential Person Now
Beverly Winikoff's AcademicInfluence.com Rankings
Beverly Winikoffmedical Degrees
Medical
#3083
World Rank
#3535
Historical Rank
Public Health
#487
World Rank
#503
Historical Rank
Beverly Winikoffphilosophy Degrees
Philosophy
#8894
World Rank
#12358
Historical Rank
Logic
#5905
World Rank
#7355
Historical Rank
Download Badge
Medical Philosophy
Beverly Winikoff's Degrees
- Doctorate Medicine University of California, San Francisco
- Masters Public Health University of California, Berkeley
Why Is Beverly Winikoff Influential?
(Suggest an Edit or Addition)Beverly Winikoff's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health (2014) (242)
- Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. (1997) (179)
- First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review. (2013) (168)
- A Systematic Review of the Relationship between Blood Loss and Clinical Signs (2013) (167)
- Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial (2005) (164)
- The obstetrician's opportunity: translating "breast is best" from theory to practice. (1980) (147)
- Use of misoprostol during pregnancy and Möbius' syndrome in infants. (1998) (138)
- The effects of birth spacing on child and maternal health. (1983) (136)
- Assessing the role of family planning in reducing maternal mortality. (1987) (132)
- Acceptability of medical abortion in early pregnancy. (1995) (129)
- ACCEPTABILITY AND FEASIBILITY OF EARLY PREGNANCY TERMINATION BY MIFEPRISTONE-MISOPROSTOL : RESULTS OF A LARGE MULTICENTER TRIAL IN THE UNITED STATES (1998) (126)
- Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial (2010) (123)
- Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial (2010) (122)
- Effects of iron supplementation on maternal hematologic status in pregnancy. (2002) (118)
- A Randomized Trial of Misoprostol Compared With Manual Vacuum Aspiration for Incomplete Abortion (2005) (115)
- Infection after medical abortion: a review of the literature. (2004) (113)
- Misoprostol for Women's Health: A Review (2002) (113)
- Community-Based Kangaroo Mother Care to Prevent Neonatal and Infant Mortality: A Randomized, Controlled Cluster Trial (2008) (102)
- Self-induction of abortion among women in the United States (2010) (101)
- Two Distinct Oral Routes of Misoprostol in Mifepristone Medical Abortion: A Randomized Controlled Trial (2008) (100)
- Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomised trial in Burkina Faso, West Africa (2007) (94)
- Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions. (2000) (94)
- Extending Outpatient Medical Abortion Services Through 70 Days of Gestational Age (2012) (91)
- Can women in less-developed countries use a simplified medical abortion regimen? (2001) (89)
- Where is the "E" in MCH? The need for an evidence-based approach in safe motherhood. (2003) (88)
- Treatment of incomplete abortion and miscarriage with misoprostol (2007) (86)
- Acceptability of home-use of misoprostol in medical abortion. (2004) (85)
- Misoprostol used alone for the termination of early pregnancy. A review of the evidence. (1999) (80)
- Dynamics of infant feeding: mothers, professionals, and the institutional context in a large urban hospital. (1986) (78)
- Postpartum hemorrhage: new insights for definition and diagnosis. (2018) (77)
- Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania (2007) (77)
- TelAbortion: evaluation of a direct to patient telemedicine abortion Service in the United States. (2019) (74)
- Comparison of misoprostol and manual vacuum aspiration for the treatment of incomplete abortion (2007) (74)
- Non-physician clinicians can safely provide first trimester medical abortion (2009) (73)
- Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-Trimester Abortion: A Randomized Controlled Trial (2011) (72)
- Bringing emergency contraception over the counter: experiences of nonprescription users in France, Norway, Sweden and Portugal. (2003) (72)
- Analysis of failure in medical abortion. (1996) (72)
- Medical treatment of missed abortion using misoprostol (2004) (71)
- Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. (2005) (71)
- Overcoming obstacles to breast-feeding in a large municipal hospital: applications of lessons learned. (1987) (70)
- Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial (2010) (70)
- FIGO's updated recommendations for misoprostol used alone in gynecology and obstetrics (2017) (69)
- Adaptation of Kangaroo Mother Care for Community-Based Application (2003) (68)
- Alternatives to a Routine Follow-Up Visit for Early Medical Abortion (2010) (67)
- The effects of birth spacing on child and maternal health (1983) (66)
- Screening and syndromic approaches to identify gonorrhea and chlamydial infection among women. (2000) (65)
- Breast feeding and bottle feeding controversies in the developing world: evidence from a study in four countries. (1989) (64)
- Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial (2019) (64)
- Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research. (2007) (62)
- Use of medicines changing the face of abortion. (2012) (61)
- Misoprostol to treat missed abortion in the first trimester (2007) (59)
- Misoprostol use in obstetrics and gynecology in Brazil, Jamaica, and the United States (2002) (58)
- The etiology of maternal mortality in developing countries: what do verbal autopsies tell us? (2001) (58)
- Safety, Efficacy and Acceptability of Mifepristone-Misoprostol Medical Abortion in Vietnam (1999) (57)
- Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone–misoprostol (2011) (56)
- Side effects of mifepristone-misoprostol abortion versus surgical abortion. Data from a trial in China, Cuba, and India. (1999) (56)
- Can at-home semi-quantitative pregnancy tests serve as a replacement for clinical follow-up of medical abortion? A US study. (2012) (56)
- Is home‐based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam (2004) (55)
- Medical abortion: A path to safe, high-quality abortion care in Latin America and the Caribbean (2013) (54)
- Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial (2006) (54)
- What measured blood loss tells us about postpartum bleeding: a systematic review (2010) (52)
- Sixteen Years of Overregulation: Time to Unburden Mifeprex. (2017) (52)
- Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone. (2011) (50)
- Rethinking postpartum family planning. (1991) (50)
- High fever following postpartum administration of sublingual misoprostol (2010) (50)
- Women's health: an alternative perspective for choosing interventions. (1988) (48)
- Anthropometric Determinants of Birth Weight (1981) (48)
- Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India. (2002) (48)
- The Acceptability of Medical Abortion In China, Cuba and India (1997) (48)
- RU OK? The acceptability and feasibility of remote technologies for follow-up after early medical abortion. (2014) (46)
- Two Regimens of Misoprostol for Treatment of Incomplete Abortion (2004) (46)
- How effective are the components of active management of the third stage of labor? (2013) (45)
- Acceptability and Feasibility of Phone Follow-up After Early Medical Abortion in Vietnam: A Randomized Controlled Trial (2014) (45)
- Abortion, revised: participants in the U.S. clinical trials evaluate mifepristone. (1998) (44)
- A randomized controlled study comparing 600 versus 1,200 microg oral misoprostol for medical management of incomplete abortion. (2005) (44)
- Effect of Immediate Compared With Delayed Insertion of Etonogestrel Implants on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial (2016) (43)
- Standardizing abortion research outcomes (STAR): a protocol for developing, disseminating and implementing a core outcome set for medical and surgical abortion☆ (2017) (43)
- Acceptability and feasibility of medical abortion in Nepal (2009) (43)
- Health and Population in Developing Countries. (1980) (43)
- Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries (2012) (43)
- A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial. (2014) (42)
- Overview of abortion cases with severe maternal outcomes in the WHO Multicountry Survey on Maternal and Newborn Health: a descriptive analysis (2014) (42)
- Home use of two doses of misoprostol after mifepristone for medical abortion: A pilot study in Sweden and France (2005) (42)
- Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic (2021) (42)
- Acceptability of home use of mifepristone for medical abortion. (2013) (42)
- Comparison of misoprostol‐only and combined mifepristone–misoprostol regimens for home‐based early medical abortion in Tunisia and Vietnam (2012) (42)
- Prevention of postpartum hemorrhage with misoprostol (2007) (41)
- Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study. (2004) (40)
- Medical Abortion: The Possibilities for Introduction in the Public Sector in South Africa (2005) (40)
- Could American women use mifepristone-misoprostol pills safely with less medical supervision? (2002) (40)
- Exploring the feasibility of obtaining mifepristone and misoprostol from the internet. (2017) (40)
- Continuing pregnancy after mifepristone and "reversal" of first-trimester medical abortion: a systematic review. (2015) (39)
- Postpartum hemorrhage care bundles to improve adherence to guidelines: A WHO technical consultation† (2019) (39)
- Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City (2014) (38)
- Alternatives to mifepristone for early medical abortion (2007) (38)
- Misoprostol for uterine evacuation in induced abortion and pregnancy failure (2007) (38)
- Validity of women's self-reported obstetric complications in rural Ghana. (2001) (37)
- Medical Abortion. (2016) (37)
- Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana (2011) (37)
- A double‐blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14–21 weeks of pregnancy (2015) (37)
- Multicenter Trial of a Simplified Mifepristone Medical Abortion Regimen (2005) (37)
- A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion. (2012) (36)
- A randomized controlled trial of 400‐μg sublingual misoprostol versus manual vacuum aspiration for the treatment of incomplete abortion in two Egyptian hospitals (2010) (36)
- Expanding access to emergency contraception in developing countries. (1995) (36)
- The medical abortion experiences of married and unmarried women in Tunis, Tunisia. (2004) (36)
- Does iron supplementation make a difference (1992) (35)
- The power of information and contraceptive choice in a family planning setting in Mexico. (2000) (35)
- Simplified medical abortion using a semi‐quantitative pregnancy test for home‐based follow‐up (2013) (35)
- Feeding infants in four societies : causes and consequences of mothers' choices (1988) (35)
- Predictors of analgesia use during supervised medical abortion. The Mifepristone Clinical Trials Group. (2000) (34)
- Misoprostol for the prevention and treatment of postpartum hemorrhage (2012) (34)
- Mortality of induced abortion, other outpatient surgical procedures and common activities in the United States. (2014) (33)
- Calibrated delivery drape versus indirect gravimetric technique for the measurement of blood loss after delivery: a randomized trial (2014) (33)
- Contraceptive use, amenorrhea, and breastfeeding in postpartum women. (1985) (33)
- A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S. (2015) (32)
- Is medical abortion acceptable to all American women: the impact of sociodemographic characteristics on the acceptability of mifepristone-misoprostol abortion. (2000) (32)
- Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial (2017) (31)
- Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone Compared With Overnight Osmotic Dilators Alone: A Randomized Controlled Trial (2015) (31)
- Community Kangaroo Mother Care: implementation and potential for neonatal survival and health in very low-income settings (2011) (31)
- Simplified medical abortion screening: a demonstration project. (2017) (30)
- Are two doses of misoprostol after mifepristone for early abortion better than one? (2007) (30)
- Can women use medical abortion without medical supervision (1997) (30)
- Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster‐randomised non‐inferiority community trial (2015) (30)
- An ecologic analysis of maternal mortality ratios. (2001) (29)
- Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial. (2016) (29)
- A comparison of women’s, providers’ and ultrasound assessments of pregnancy duration among termination of pregnancy clients in South Africa (2007) (29)
- Misoprostol for postpartum hemorrhage: Moving from evidence to practice (2012) (29)
- Ectopic Pregnancy and Medical Abortion (2004) (29)
- Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol. (2009) (28)
- Comment on “Misoprostol Impairs Female Reproductive Tract Innate Immunity against Clostridium sordellii” (2008) (28)
- Mifepristone abortion outside the urban research hospital setting in India (2001) (28)
- Treatment of postpartum hemorrhage with misoprostol (2007) (28)
- Serial multilevel urine pregnancy testing to assess medical abortion outcome: a meta-analysis. (2017) (27)
- Acceptability and feasibility of phone follow-up with a semiquantitative urine pregnancy test after medical abortion in Moldova and Uzbekistan. (2015) (27)
- Mifepristone Followed in 24 Hours to 48 Hours by Misoprostol for Late First-Trimester Abortion (2007) (27)
- Integrating medical abortion into safe abortion services: experience from three pilot sites in South Africa (2008) (27)
- Misoprostol alone for early abortion: an evaluation of seven potential regimens. (2005) (27)
- Misoprostol as first‐line treatment for incomplete abortion at a secondary‐level health facility in Nigeria (2012) (26)
- Increasing women's choices in medical abortion: A study of misoprostol 400 μg swallowed immediately or held sublingually following 200 mg mifepristone (2009) (26)
- How well do postpartum blood loss and common definitions of postpartum hemorrhage correlate with postpartum anemia and fall in hemoglobin? (2019) (26)
- Simultaneous Administration Compared With a 24-Hour Mifepristone–Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled Trial (2016) (26)
- Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicenter trial in the United States. Mifepristone Clinical Trials Group. (1998) (26)
- Postpartum haemorrhage: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data☆ (2016) (25)
- Misoprostol alone--a new method of medical abortion? (2000) (25)
- A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64-70 days and 71-77 days of gestation. (2020) (25)
- A Fatal Case of Clostridium sordellii Septic Shock Syndrome Associated With Medical Abortion (2004) (24)
- Magnesium sulphate for prevention of eclampsia: are intramuscular and intravenous regimens equivalent? A population pharmacokinetic study (2013) (24)
- Decentralizing postabortion care in Senegal with misoprostol for incomplete abortion (2014) (24)
- Facility and personnel factors influencing magnesium sulfate use for eclampsia and pre‐eclampsia in 3 Indian hospitals (2011) (23)
- The Maternal Depletion Syndrome: Clinical Diagnosis or Eco-Demographic Condition? (1987) (23)
- Acceptability and feasibility of mifepristone-misoprostol for menstrual regulation in Bangladesh. (2013) (23)
- Vaginal and Rectal Clostridium sordellii and Clostridium perfringens Presence Among Women in the United States (2016) (23)
- Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days' LMP: a randomized controlled trial. (2010) (23)
- Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial (2016) (23)
- Foregoing Rh testing and anti-D immunoglobulin for women presenting for early abortion: a recommendation from the National Abortion Federation's Clinical Policies Committee. (2019) (22)
- Reduction of the cesarean delivery rate in Ecuador (2000) (22)
- Comparative study between single dose 600 microg and repeated dose of oral misoprostol for treatment of incomplete abortion. (2004) (22)
- Improving post-abortion care in a public hospital in Oaxaca, Mexico (1997) (22)
- Reaching women where they are: eliminating the initial in-person medical abortion visit. (2015) (22)
- Intramuscular injection, intravenous infusion, and intravenous bolus of oxytocin in the third stage of labor for prevention of postpartum hemorrhage: a three-arm randomized control trial (2019) (21)
- Blood loss with mifepristone–misoprostol abortion: measures from a trial in China, Cuba and India (1998) (21)
- Medical services to save mothers lives: feasible approaches to reducing maternal mortality. (1991) (21)
- Nutrition, population, and health: some implications for policy. (1978) (21)
- Should emergency contraceptive pills be available without prescription? (1998) (21)
- Results and lessons learned from a small medical abortion clinical study in Turkey. (2004) (21)
- Issues in the design of breastfeeding research. (1981) (21)
- Postpartum Hemorrhage Management, Risks, and Maternal Outcomes: Findings From the World Health Organization Multicountry Survey on Maternal and Newborn Health (2015) (21)
- Efficacy and acceptability of a mifepristone–misoprostol combined regimen for early induced abortion among women in Mexico City (2014) (20)
- Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make? (2012) (20)
- Induction of labour in pre-eclamptic women: a randomised trial comparing the Foley balloon catheter with oral misoprostol (2014) (20)
- The effectiveness and safety of introducing condom-catheter uterine balloon tamponade for postpartum haemorrhage at secondary level hospitals in Uganda, Egypt and Senegal: a stepped wedge, cluster-randomised trial (2019) (19)
- Misoprostol for prevention and treatment of postpartum hemorrhage: What do we know? What is next? (2012) (19)
- Outcomes and Safety of History-Based Screening for Medication Abortion (2022) (19)
- Treatment approaches for preeclampsia in low-resource settings: A randomized trial of the Springfusor pump for delivery of magnesium sulfate. (2012) (19)
- The introduction of first trimester medical abortion in Armenia (2014) (19)
- The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in rural Uganda: a community-based, placebo-controlled randomised trial (2015) (19)
- Differences in efficacy, differences in providers: results from a hazard analysis of medical abortion. (2004) (18)
- "Safety, Efficacy, and Acceptability of Medical Abortion in China, Cuba, and India: A Comparative Trial of Mifepristone-Misoprostol versus Surgical Abortion." (1997) (18)
- Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial. (2009) (18)
- Review of the literature on patient satisfaction with early medical abortion using mifepristone and misoprostol (2011) (18)
- Providing mifepristone-misoprostol medical abortion: the view from the clinic. (1999) (18)
- Infant feeding in urban Kenya: a pattern of early triple nipple feeding. (1986) (18)
- Improving postabortion care with limited resources in a public hospital in Oaxaca Mexico. (1999) (18)
- Celebrating mother and child on the fortieth day: The Sfax Tunisia postpartum program (1989) (18)
- A prospective open‐label study of home use of mifepristone for medical abortion in Nepal (2015) (17)
- Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone. (2016) (17)
- Clostridium sordellii infection in medical abortion. (2006) (17)
- Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan (2014) (17)
- Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria (2014) (17)
- Correction: A Systematic Review of the Relationship between Blood Loss and Clinical Signs (2013) (17)
- Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10 weeks of pregnancy in Kazakhstan (2016) (17)
- Feeding Infants in Four Societies (1989) (16)
- Expanded safety and acceptability of the candidate vaginal microbicide Carraguard® in South Africa. (2010) (16)
- Second trimester medical abortion with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia (2017) (16)
- Treatment of Postpartum Hemorrhage With Sublingual Misoprostol Versus Oxytocin in Women Receiving Prophylactic Oxytocin: A Double-blind, Randomized, Noninferiority Trial (2011) (16)
- Oral misoprostol for the management of incomplete abortion in Ecuador (2011) (16)
- Nutrition and food policy: the approaches of Norway and the United States. (1977) (15)
- Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions (2007) (15)
- Buccal misoprostol for treatment of fetal death at 14-28 weeks of pregnancy: a double-blind randomized controlled trial. (2014) (15)
- A consensus regimen for early abortion with misoprostol (2004) (15)
- Mifepristone medical abortion in Albania: Results from a pilot clinical research study (2006) (15)
- Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals: implications for task shifting (2013) (15)
- Abortion: what is the problem? (2012) (14)
- Effectiveness of lifesaving skills training and improving institutional emergency obstetric care readiness in Lam Dong, Vietnam. (2005) (14)
- Postpartum hemorrhage prevention in Nepal: a program assessment (2017) (14)
- A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routes (2016) (13)
- Toward Safe and Effective Medical Abortion (1998) (13)
- Incidence of postpartum infection after vaginal delivery in Viet Nam. (2005) (13)
- Knowledge, attitudes, and practice of abortion among women and doctors in Armenia (2009) (13)
- Foley catheter vs. oral misoprostol to induce labour among hypertensive women in India: a cost‐consequence analysis alongside a clinical trial (2018) (13)
- Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan (2013) (13)
- How much Supervision is Necessary for Women Taking Mifepristone and Misoprostol for Early Medical Abortion? (2008) (12)
- Improving postabortion care in a public hospital in Mexico. (2002) (12)
- Misoprostol-induced fever and genetic polymorphisms in drug transporters SLCO1B1 and ABCC4 in women of Latin American and European ancestry. (2015) (12)
- Infant feeding in Bangkok Thailand. (1988) (12)
- Pregnancy failure and misoprostol--time for a change. (2005) (11)
- Research on determinants of infant feeding practices: a conceptual framework. (1981) (11)
- Knowledge and attitudes about abortion legislation and abortion methods among abortion clients in Latvia (2005) (11)
- DMPA and HIV: do we need a trial? (2014) (11)
- Case finding and case management of chlamydia and gonorrhea infections among women: what we do and do not know. (1999) (11)
- The influence of maternal employment on infant feeding. (1988) (11)
- Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia (2016) (10)
- Mifepristone label laws and trends in use: recent experiences in four US states. (2015) (10)
- Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail. (2021) (10)
- A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion (2018) (10)
- Nutrition and national policy (1980) (10)
- Early abortion with buccal versus sublingual misoprostol alone: a multicenter, randomized trial. (2019) (9)
- Exploring potential interest in missed period pills in two US states. (2020) (9)
- Does route matter? Impact of route of oxytocin administration on postpartum bleeding: A double-blind, randomized controlled trial (2019) (9)
- The influence of health services on infant feeding. (1988) (9)
- Misoprostol for the management of postpartum bleeding: A new approach (2012) (9)
- O207 ROUTE OF ADMINISTRATION OF OXYTOCIN IN PREVENTION OF POSTPARTUM HEMORRHAGE (2012) (9)
- Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia (2016) (9)
- A double-blind, randomized controlled trial to explore oral tranexamic acid as adjunct for the treatment for postpartum hemorrhage (2020) (8)
- Embracing post-fertilisation methods of family planning: a call to action (2013) (8)
- Medical abortion in China: results of a fact-finding mission. (2002) (8)
- Executive summary: the Safe Motherhood demonstration projects. (1998) (8)
- Vaginal and rectal clostridial colonization among women of reproductive age in the United States (2010) (8)
- Using misoprostol to treat postpartum hemorrhage in home deliveries attended by traditional birth attendants (2019) (7)
- Maternal health in the age of AIDS: implications for health services in developing countries. (1994) (7)
- Accounting for time: insights from a life-table analysis of the efficacy of medical abortion. (2004) (7)
- Infant feeding in Bogota Colombia. (1988) (7)
- What happens when we routinely give doxycycline to medical abortion patients? (2015) (7)
- Acceptability and feasibility of outpatient medical abortion with mifepristone and misoprostol up to 70 days gestation in Singapore. (2018) (6)
- Nutrition, population and health: theoretical and practical issues. (1980) (6)
- Condom promotion in microbicide trials. (2000) (6)
- Rethinking postpartum health care (1993) (6)
- Clinic‐level introduction of medical abortion in Vietnam (2012) (6)
- A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries. (2020) (6)
- Defining maternal depletion syndrome. (1993) (6)
- O204 DOES THE EFFECT OF OXYTOCIN PROPHYLAXIS ON POST‐PARTUM BLOOD LOSS DEPEND ON ROUTE OF ADMINISTRATION? (2012) (6)
- Providers, Pills and Power: The US Mifepristone Abortion Trials and Caregivers’ Interpretations of Clinical Power Dynamics (2001) (6)
- Fifteen years: looking back and looking forward. (2015) (6)
- Why research on contraceptive user perspectives deserves public sector support: a free-market analysis. (1997) (5)
- Studying the Acceptability and Feasibility of Medical Abortion (1992) (5)
- Congo red test for identification of preeclampsia: Results of a prospective diagnostic case-control study in Bangladesh and Mexico (2020) (5)
- Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a multi-level pregnancy test (MLPT) for home monitoring of hCG trends after assisted reproduction (2017) (5)
- The Quality of Family Planning Services For Breastfeeding Women in Senegal (1998) (5)
- The Whole Truth About Contraception: A Guide to Safe and Effective Choices (1997) (5)
- Infant feeding in Semarang Indonesia. (1988) (5)
- Could second-trimester medical abortion be offered as a day service? Assessing the feasibility of a 1-day outpatient procedure using pooled data from six clinical studies. (2019) (5)
- Mifepristone-misoprostol medical abortion: who will use it and why? (1998) (5)
- Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: Results of two clinical trials (2013) (5)
- Critical Issues in Reproductive Health Misoprostol and Teratogenicity : Reviewing the Evidence Report of a Meeting (2002) (5)
- Rethinking postpartum health care. Proceedings of a seminar presented under the Population Councils Robert H. Ebert Program on Critical Issues in Reproductive Health and Population December 10-11 1992 the Population Council New York New York. (1993) (4)
- Use of an at‐home multilevel pregnancy test and an automated call‐in system to follow‐up the outcome of medical abortion (2019) (4)
- I237 Treatment of postpartum hemorrhage with sublingual misoprostol versus oxytocin: Results from a randomized, non‐inferiority trial among women not exposed to oxytocin during labor (2009) (4)
- Misoprostol for Womenʼs Health: A Review (2002) (4)
- Profound Hyperthermia After Postpartum Rectal Misoprostol Administration. (2016) (4)
- Buccal vs. sublingual misoprostol alone for early pregnancy termination in two Latin American settings: a randomized trial (2017) (4)
- I195 Introduction of misoprostol for incomplete abortion care in Latin America: Evidence from Ecuador (2009) (4)
- Introduction and provision of medical abortion: a tale of two countries in which technology is necessary but not sufficient. (2011) (4)
- The infant feeding study: Bangkok site report. (1981) (4)
- O202 Bleeding following surgical (MVA) and medical (400 μg sublingual misoprostol) treatment of incomplete abortion (2009) (4)
- Unsafe abortion and strategies to reduce its impact on women’s lives (2010) (4)
- Use of misoprostol in third stage of labour (2002) (4)
- The infant feeding study: Nairobi site report. (1981) (4)
- Medication abortion in the private sector in South Africa (2006) (4)
- O46 A comparison of drape estimation and a standardized weight method for the measurement of postpartum blood loss (2009) (4)
- Controlled cord traction in active management of the third stage of labour (2012) (3)
- Rates of serious infection after medical abortion. (2009) (3)
- Medical abortion outcomes following quickstart of contraceptive implants and depot-medroxyprogesterone acetate (2015) (3)
- Limitations of maternal care to improve maternal health (1991) (3)
- A randomized controlled trial comparing repeat doses of 400 mcg sublingual to buccal misoprostol after mifepristone for termination of pregnancy 13–21 weeks (2017) (3)
- Feasibility of a hospital outpatient day procedure for medication abortion at 13-18weeks gestation: findings from Nepal. (2019) (3)
- Abortion is for women (2007) (3)
- Standardizing abortion research outcomes (STAR): results from an international consensus development study. (2021) (3)
- When Patients Change Their Minds After Starting an Abortion: Guidance from the National Abortion Federation's Clinical Policies Committee. (2020) (3)
- Postpartum family planning. What is it? Where does it come from? And what can it be? (1990) (3)
- O645 Preeclampsia in low‐resource settings: A randomized trial of IV MgSO4 via flow controlled pump (2009) (3)
- Induction of Labor in Preeclamptic Women in India: A Randomized Trial Comparing Foley Catheter With Oral Misoprostol [8I] (2016) (3)
- Postpartum care and family planning services. (1994) (3)
- [238-POS]: Oral antihypertensive regimens for management of severe hypertension in pregnancy: Results from a pilot study in India (2015) (3)
- A descriptive analysis of medical abortion commodity availability and pricing at retail outlets in 44 countries across four regions globally (2021) (3)
- Is the risk approach effective in maternal care? (1995) (3)
- Sensitivity and Specificity of Placental Proteins for Gestational Age Screening: An Exploratory Study. (2020) (3)
- Achieving community-based postpartum follow up in eastern Uganda: the field experience from the MamaMiso Study on antenatal distribution of misoprostol (2017) (3)
- Preliminary results of the role of semiquantitative pregnancy tests in medical abortion provision (2010) (3)
- I86 Treatment of postpartum hemorrhage with sublingual misoprostol versus oxytocin: Results from a randomized non‐inferiority trial among women receiving prophylactic oxytocin (2009) (3)
- Nigeria 1999: results from the Demographic and Health Survey. (2001) (2)
- Scaling up interventions: findings and lessons learned from an external evaluation of Niger’s National Initiative to reduce postpartum hemorrhage (2019) (2)
- Mifepristone pretreatment Followed by Misoprostol 200mcg Buccal for the Medical Management of Intrauterine Fetal Death at 14-28 Weeks: A Randomized, Placebo-controlled, Double Blind Trial. (2020) (2)
- A cluster-randomized, non-inferiority trial comparing use of misoprostol for universal prophylaxis vs. secondary prevention of postpartum hemorrhage among community level births in Egypt (2020) (2)
- High fever after sublingual administration of misoprostol for treatment of post‐partum haemorrhage: a hospital‐based, prospective observational study in Argentina (2020) (2)
- Acceptability of first trimester medical abortion (1994) (2)
- Misoprostol for treatment of incomplete abortion in Madagascar (2006) (2)
- The TelAbortion Project: Delivering the Abortion Pill to your Doorstep by Telemedicine and Mail [5E] (2018) (2)
- Trends in Postpartum Contraceptive Choice (1984) (2)
- The unmet family planning needs of breastfeeding women: lessons from Nigeria and Senegal. (1996) (2)
- Testing a home-based model of care using misoprostol for prevention and treatment of postpartum hemorrhage: results from a randomized placebo-controlled trial conducted in Badakhshan province, Afghanistan (2020) (2)
- The Effectiveness and Safety of Introducing Condom-catheter Uterine Balloon Tamponade for Postpartum Hemorrhage at Secondary Level Hospitals in Uganda, Egypt, and Senegal: A Stepped Wedge, Cluster-randomized Trial (2020) (2)
- The Safety and Feasibility of a Family First Aid Approach for the Management of Postpartum Hemorrhage in Home Births: A Pre-post Intervention Study in Rural Pakistan (2020) (2)
- PL.03 Self-Administration of Misoprostol to Prevent Bleeding After Homebirths in Uganda: A Pilot Placebo-Controlled, Randomised Trial (2013) (2)
- The infant study: Semarang site report. (1981) (2)
- Comment on "Is It Safe to Provide Abortion Pills Over The Counter? A Study on Outcome Following Self-Medication with Abortion Pills". (2015) (2)
- The influence of infant feeding practices on morbidity and child growth. (1988) (2)
- Use of a semiquantitative pregnancy test (SQPT) for medical abortion follow-up (2015) (2)
- Technical working group A report: Breastfeeding promotion and support in hospitals and maternity care institutions (1990) (2)
- The infant feeding study: Bogota site report. (1981) (2)
- O155 OUTCOMES OF A DOUBLE‐BLIND RANDOMIZED TRIAL COMPARING MISOPROSTOL‐ONLY TO MIFEPRISTONE+MISOPROSTOL FOR HOME‐BASED EARLY MEDICAL ABORTION (2012) (2)
- Patterns of infant feeding in four urban areas: Bangkok Bogota Nairobi and Semarang (1984) (2)
- Medical abortion with mifepristone and misoprostol at 13–22 weeks: how long between the mifepristone and the misoprostol? (2015) (2)
- Delivering women centered maternity care with limited resources: Grenada (1994) (2)
- Mifepristone and sublingual misoprostol versus sublingual misoprostol alone for missed abortion: Results of a randomized placebo-controlled trial (2019) (2)
- Multi-level pregnancy test use for medical abortion follow-up after 63 days' gestation: Evidence from prenatal hCG data. (2020) (2)
- Outpatient mifepristone–misoprostol medical abortion through 77 days of gestation (2016) (2)
- The impact of health services on breastfeeding: common themes from developed and developing worlds. (1984) (1)
- "Who is driving you home today?" Escort policy as a barrier to abortion access (2022) (1)
- Medical abortion with misoprostol only vs. mifepristone plus misoprostol: results from a randomized controlled trial (2009) (1)
- Single dose letrozole and misoprostol for termination of pregnancy through 63 days' gestation: A pilot study. (2022) (1)
- Postpartum bleeding is reduced with sublingual powdered misoprostol when compared with oxytocin injection, but a new formulation of misoprostol is unlikely to revolutionise postpartum haemorrhage care (2012) (1)
- Oral Misoprostol alone versus oral misoprostol followed by oxytocin for labour induction in women with hypertension in pregnancy (MOLI): protocol for a randomised controlled trial (2021) (1)
- Mifepristone‐misoprostol medical abortion: Simplifying the regimen (2000) (1)
- The Contraceptive Handbook: A Guide to Safe and Effective Choices (1992) (1)
- Contraception during breastfeeding: a clinicians sourcebook. (1988) (1)
- Postpartum infection, pain and experiences with care among women treated for postpartum hemorrhage in three African countries: A cohort study of women managed with and without condom-catheter uterine balloon tamponade. (2021) (1)
- 199. Oral antihypertensive treatment of severe hypertension in pregnancy – A randomized trial of 3 regimens (2018) (1)
- Role of semi-quantitative urine pregnancy tests in medical abortion provision (2011) (1)
- O627 EFFECTIVENESS OF THE COMPONENTS OF ACTIVE MANAGEMENT OF THE THIRD STAGE OF LABOR (2012) (1)
- Increasing women's choice and access to safe abortion services in Turkey: a study of the efficacy and acceptability of medical abortion in four sites (2005) (1)
- A prospective study of mifepristone and unlimited dosing of sublingual misoprostol for termination of second-trimester pregnancy in Uzbekistan and Ukraine (2019) (1)
- Claims of misoprostol use based on blood sampling should be viewed with skepticism (2014) (1)
- [First experience of the use of misoprostol as post-abortion care in Libreville, Gabon]. (2014) (1)
- The supreme court and the Partial-Birth Abortion Ban Act of 2003: a political procedure replaces woman-centered care. (2007) (1)
- Providing Abortion in Low‐Resource Settings (2009) (1)
- Infant feeding study : Semarang site report (1983) (1)
- How effective are the components of active management of the third stage of labor (2011) (1)
- Use of an at-home multilevel pregnancy test and an automated telephone system to simplify medical abortion follow-up (2017) (1)
- I288 Introducing medical abortion in the public health sector in Mexico (2009) (1)
- The potential of two non-vaginal routes of misoprostol administration following mifepristone for medical abortion up to 63 days gestation (2007) (1)
- O553 Preliminary results of the semi‐quantitative pregnancy test and its impact on reproductive health service provision (2009) (1)
- The relationship of nutrition and population. (1979) (1)
- Re: Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy. (2010) (1)
- 117: Misoprostol for treatment of intrauterine fetal death at 14-28 weeks of pregnancy (2012) (1)
- Cervical preparation before second-trimester dilation and evacuation: a multicenter randomized trial comparing osmotic dilators alone to dilators plus adjunctive misoprostol or mifepristone (2014) (1)
- Family planning and the health of women and children (1987) (1)
- Results from a clinical study offering women in Ghana and Nigeria mifepristone abortion for termination of unwanted pregnancy (2006) (1)
- Analytical Comparison of Pregnancy-Associated Plasma Protein-A (PAPP-A) Immunoassays for Biochemical Determination of Gestational Age. (2021) (1)
- Sublingual Misoprostol for the Treatment of Postpartum Hemorrhage (2012) (1)
- Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study (2016) (1)
- OS034. Magnesium sulfate for prevention of eclampsia: Are intramuscularand intravenous regimens equivalent? (2012) (1)
- 'Of course, women will adopt it!': A qualitative study on the acceptability of medical menstrual regulation in Senegal. (2022) (1)
- A survey study of marijuana use for pain management during first-trimester medical abortion (2016) (1)
- I93 Understanding postpartum hemorrhage: Its frequency and treatment (2009) (0)
- Early Triple-Nipple Infant Feeding in Nairobi Women and the Relationship of this to Lactational Amenorrhoea (1987) (0)
- O172 A randomized controlled study of sublingual vs. oral misoprostol (400 μg) following mifepristone (200 mg) for medical abortion up to 63 days L.M.P. in Tunisia (2009) (0)
- O141 Alternatives to a routine follow‐up visit for early medical abortion (2009) (0)
- Letter to the EditorResponse to Letter to the Editor (2012) (0)
- THE UNMET FAMILY PLANNING NEEDS OF BREAS11fEEDING WOMEN (1996) (0)
- Original research article A randomized controlled study comparing 600 versus 1200 Ag oral misoprostol for medical management of incomplete abortion (2005) (0)
- CLINICAL ORAL ABSTRACTS (2021) (0)
- Early Pregnancy Termination (2007) (0)
- Society of Family Planning Annual Meeting 2021. (2021) (0)
- Randomised trials of medical abortion provide some but not all the answers (2022) (0)
- O674 Mifepristone and misoprostol versus misoprostol alone for mid‐trimester termination of pregnancy (14–21 weeks LMP): A randomized‐controlled double‐blinded trial (2009) (0)
- Maternal mortality: What do we really know from verbal autopsies? (2000) (0)
- Misoprostol for treatment of incomplete abortion in Sub-Saharan Africa (2005) (0)
- What happens when medical abortion services give women the option of taking mifepristone home (2015) (0)
- Misoprostol use in the community to reduce maternal death (2010) (0)
- O034 MENSTRUAL REGULATION USING MEDICATION IS ACCEPTABLE AND FEASIBLE IN BANGLADESH (2012) (0)
- spasm, regularizing cardiovascular abnormality by regularizing cardiac cycle by regulating ventricular contraction and improving peripheral circulation at the same time perk up respiratory system (2001) (0)
- O194 INTRODUCTION OF MISOPROSTOL AS FIRST LINE TREATMENT OF INCOMPLETE ABORTION: THE SENEGAL EXPERIENCE (2012) (0)
- The effect of health services on breastfeeding in developing countries. (1985) (0)
- O626 RELATIONSHIP BETWEEN TIME TO PLACENTAL DELIVERY AND POST‐PARTUM BLOOD LOSS (2012) (0)
- Breast-feeding and prevention of necrotizing enterocolitis [letter] (1982) (0)
- Treatment of postpartumhemorrhagewithmisoprostol (2007) (0)
- Use of a semi-quantitative pregnancy test (SQPT) to monitor hCG levels after assisted reproduction (2014) (0)
- From the Editor (1997) (0)
- Mifepristone and misoprostol vs. misoprostol alone for mid-trimester termination of pregnancy (14–21 weeks LMP): a randomized, controlled, double-blinded trial (2011) (0)
- Effects of standard 60 mg supplemental iron on maternal hematologic status in pregnancy. (1993) (0)
- Does a repeat dose of misoprostol following mifepristone for early abortion increase efficacy (2006) (0)
- PAPP-A as a screening tool for assessment of gestational age before medication abortion in an intended-use population. (2023) (0)
- Randomized study of sublingual and oral misoprostol following mifepristone 200 mg for abortion up to 63 days' gestation in Moldova (2007) (0)
- Condom promotion in microbicide trials [letter] (2000) (0)
- The extended gestational age medical abortion study: the effectiveness of medical abortion with 200 mg mifepristone and 400 mcg sublingual misoprostol at 57–63 days vs. 64–70 days gestation (2011) (0)
- The Induction with Foley OR Misoprostol (INFORM) Study dataset. A dataset of 602 women with hypertensive disease in pregnancy, in India, randomised to either Foley catheter or oral misoprostol for induction of labour (2021) (0)
- O294 NATIONAL EXPANSION STUDY OF MEDICAL ABORTION TO 63 DAYS LMP IN TUNISIAN FAMILY PLANNING CLINICS (2012) (0)
- Assessment of life saving skills (LSS) in Vietnam (2000) (0)
- An emerging technology for women ’ s heal th Report of a seminar (2004) (0)
- Abortion bans and their impacts: A view from the United States (2023) (0)
- Can a multilevel pregnancy test (MLPT) be used for medical abortion follow-up among women at more than 63 days’ gestation? Evidence from prenatal hCG data (2017) (0)
- Special issues of IUD use in resource-poor settings (1992) (0)
- Acceptability of an outpatient regimen of medical abortion with mifepristone and 800 mcg misoprostol administered buccally or sublingually at 71–84 days of gestation: a series of exploratory studies (2014) (0)
- Health services as a determinant of infant feeding practices: preliminary findings from the infant feeding study. (1984) (0)
- 428. Trials in low-resource settings: the INFORM study (oral misoprostol versus balloon induction in women with PIH or pre-eclampsia) (2018) (0)
- Health and population in developing countries (Bellagio, April, 1979). (1980) (0)
- Original research article Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days' LMP: a randomized controlled trial ☆ (2010) (0)
- O184 Two‐pill regimens of misoprostol after mifepristone medical abortion through 63 days' LMP: A randomized controlled trial of buccal and sublingual misoprostol (2009) (0)
- Breast-feeding and prevention of necrotizing enterocolitis. (1982) (0)
- O140 Alternatives to routine ultrasound for eligibility assessment prior to early medical abortion (2009) (0)
- Should emergency contraceptive pills be available without prescription in Europe? (1998) (0)
- ' s response to reviews Title : How Effective are the Components of Active Management of the Third Stage of Labor ? (2013) (0)
- [Yes it can be done. How to improve the quality of post-abortion care in a public hospital. The case of Oaxaca Mexico] (1998) (0)
- Family Planning Association of Castille and Leon (1998) (0)
- Women’s compliance with self-care instructions after induced abortion (2016) (0)
- O673 Medical abortion with misoprostol only versus mifepristone plus misoprostol: Results from a randomized controlled trial (2009) (0)
- Authors' Response to an Earlier Review (1991) (0)
- Explaining the differential effects of breastfeeding on duration of amenorrhea: frequency and patterns of breastfeeding. (1984) (0)
- Setting up a medical abortion service for failure. (2009) (0)
- Foley Catheterization Versus Oral Misoprostol for Induction of Labour in Hypertensive Women in India (INFORM): A Multicenter, Open-label, Randomized Controlled Trial (2018) (0)
- Mailing abortion pills does not delay care: a cohort study comparing mailed to in-person dispensing of abortion medications in the United States. (2023) (0)
- Introducing misoprostol for treatment of incomplete abortion: A feasibility and acceptability study in secondary-level health facilities in Myanmar. (2023) (0)
- P229 The effect of active management on postpartum blood loss in a Turkish maternity hospital (2009) (0)
- Contraception during breastfeeding: a clinicians sourcebook. 2nd ed. (1997) (0)
- O927 Increasing access to safe abortion through the introduction of medical abortion in Ghana: Results from a clinical study offering medical abortion to women in Ghana (2009) (0)
- O792 Magnesium sulfate for pre‐eclampsia: A study of attitudes and barriers in India (2009) (0)
- abortion into a large teaching hospital is difficult, but rather how definitively this particular site set itself up for failure. (2009) (0)
- P2.192 Vaginal Epithelial Thickness and Serum Hormone Levels by Body Mass Index at the Luteal and Follicular Phases of the Menstrual Cycle (2013) (0)
- The extended gestational age medical abortion study: the effectiveness of medical abortion with mifepristone and misoprostol at 57–63 days versus 64–70 days gestation (2010) (0)
- Health and population in developing countries. Selected papers originally presented at the Bellagio Conference, April 18-21, 1979, held under the auspices of the Ford Foundation. (1980) (0)
- In Reply to PAPP-A Results Cannot Be Used to Accurately Estimate Gestational Age. (2022) (0)
- Achieving community-based postpartum follow up in eastern Uganda: the field experience from the MamaMiso Study on antenatal distribution of misoprostol (2017) (0)
- Postpartum Hemorrhage: New Insights for Definition and Diagnosis (2019) (0)
- I385 WHY MISOPROSTOL MATTERS (2012) (0)
- O93 Side effects following misoprostol administration for treatment of primary postpartum hemorrhage in Quito, Ecuador (2009) (0)
- Original research article A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial ☆☆,★,★★ (2014) (0)
- The Induction with Foley OR Misoprostol (INFORM) Study dataset. A dataset of 602 women with hypertensive disease in pregnancy, in India, randomised to either Foley catheter or oral misoprostol for induction of labour (2021) (0)
- P3.449* The promise of estriol cream for prevention of vaginal infection in premenopausal women (2013) (0)
- Improving Current Therapies and Exploring New Options in Abortifacient Technology (2005) (0)
This paper list is powered by the following services:
